New York State Common Retirement Fund’s GT Biopharma GTBP Stock Holding History

New York State Common Retirement Fund’s Portfolio GTBP Stock Details GTBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5	Closed	–	–	3346
2022 Q2	$0	Sell	5 -267	-98%	-$20.2K	﹤0.01%	3502
2022 Q1	$24K	Hold	272	–	–	﹤0.01%	3277
2021 Q4	$25K	Sell	272 -2	-0.7%	-$299	﹤0.01%	3286
2021 Q3	$55K	Sell	274 -406	-60%	-$122K	﹤0.01%	3232
2021 Q2	$316K	Buy	+680	New	+$283K	﹤0.01%	2822

Other funds holding GTBP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

New York State Common Retirement Fund's GTBP Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of GT Biopharma (GTBP) in Q3 2022, closing a stake of 5 shares.

New York State Common Retirement Fund first reported a position in GTBP in Q2 2021 and held it in 5 quarters. The position peaked at $316K in Q2 2021. 34 funds tracked by Wall St. Rank hold GTBP as of Q3 2022.

New York State Common Retirement Fund reported no remaining GT Biopharma position as of Q3 2022 after selling out during the quarter.
New York State Common Retirement Fund sold 5 GT Biopharma shares in Q3 2022.
New York State Common Retirement Fund first reported a position in GT Biopharma in Q2 2021 and held it in 5 quarters.
New York State Common Retirement Fund's GT Biopharma position peaked at $316K in Q2 2021.
34 funds tracked by Wall St. Rank held GT Biopharma as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.